Leptin levels in women with polycystic ovary syndrome before and after treatment with diazoxide

European Journal of Endocrinology

Volumn 139, Issue 2, 1998, Pages 184-189

  Krassas, G E ^a,e   Kaltsas, T T ^a   Pontikides, N ^a   Jacobs, H ^b   Blum, W ^c   Messinis, I ^d  

^a PANAGIA GENERAL HOSPITAL   (Greece)

^b MIDDLESEX HOSPITAL   (United Kingdom)

^c LILLY DEUTSCHLAND GMBH   (Germany)

^d UNIVERSITY OF THESSALY   (Greece)

^e NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; DIAZOXIDE; FOLLITROPIN; GENE PRODUCT; GLUCOSE; INSULIN; LEPTIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MULTIPLE REGRESSION; OBESITY; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0031844422     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1390184     Document Type: Article

References (25)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 425-432.
2. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL & Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996 45 1455-1462.
3. Halaas JL, Gajawala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995 269 543-546.
4. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995 269 540-543.
5. Barash IA, Cheung CC, Weigle DS, Ren H, Kabigting EE, Kuijper JL et al. Leptin is a metabolic signal to the reproductive system. Endocrinology 1996 137 3144-3147.
6. Brzechffa PR, Jakimiuk AJ, Agarwal SK, Weitsman SP, Buyalos RP & Magoffin DA. Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1996 81 4166-4169.
7. Chapman IM, Wittert GA & Norman RJ. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clinical Endocrinology 1997 46 175-181.
8. Laughlin GA, Morales AJ & Yen SSC. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 1997 82 1692-1696.
9. Mantzoros CS, Dunaif A & Flier JS. Leptin concentrations in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1997 82 1687-1691.
10. Rouru J, Anttila L, Koskinen P, Penttila T-A, Irjala K, Huupponen R et al. Serum leptin concentrations in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1997 82 1697-1700.
11. Spicer LJ & Echternkamp SE. The ovarian insulin and insulin-like growth factor system with an emphasis on domestic animals. Domestic Animal Endocrinology 1995 12 223-245.
12. Goldzieher JW. Polycystic ovarian disease. Fertility and Sterility 1981 35 371-395.
13. Fajans SS & Floyd JC Jr. Diagnosis and medical management of insulinomas. Annual Review of Medicine 1979 30 313-329.
14. Adams J, Poison DW & Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. British Medical Journal 1986 293 355-359.
15. Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage and testosterone. Journal of Clinical Endocrinology and Metabolism 1997 82 2904-2910.
16. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R et al. Acute and chronic effect of insulin on leptin production in humans - studies in vivo and in vitro. Diabetes 1996 45 699-701.
17. Hardie LJ, Rayner DV, Holmes S & Trayhurn P. Circulating leptin levels are modulated by fasting, cold exposure and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELJSA. Biochemical and Biophysical Research Communications 1996 223 660-665.
18. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J & Lardt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996 45 695-698.
19. Korbonits M, Trainer PJ, Little JA. Edwards R, Kopelmar PG, Besser GM et al. Leptin levels do not change acutely with food administration in normal or obese subjects but are negatively correlated with pituitary-adrenal activity. Clinical Endocrinology 1997 46 751-757.
20. Nestler JE, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN et al. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1989 68 1027-1032.
21. Baxter RC & Cowell CT. Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. Journal of Clinical Endocrinology and Metabolism 1987 65 432-440.
22. Chehab FF, Lim ME & Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genetics 1996 12 318-320.
23. Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D et al. Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nature Medicine 1996 2 585-589.
24. Spicer LJ & Francisco CC. The adipose obese gene product, leptin: evidence of a direct inhibitory role in ovarian function. Endocrinology 1997 138 3374-3379.
25. Hardie L, Trayhurn P, Abramovich D & Fowler P. Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy. Clinical Endocrinology 1997 47 101-106.